<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>To study the clinical presentation of the first episode of <z:hpo ids='HP_0005110'>atrial fibrillation</z:hpo> (AF), treatment tactics and its compliance with current recommendations, features of the further clinical course and prognosis in patients with AF we performed a retrospective study on data of Polyclinic No 1 of the General Management Department of the President of RF  </plain></SENT>
<SENT sid="1" pm="."><plain>We analyzed data from 58 patients (36 men, 22 women) from January 2009 to September 2011 inclusive </plain></SENT>
<SENT sid="2" pm="."><plain>The first episode of AF was recorded in the age from 48 to 90 years (in 39.7% of patients - aged 80 to 90 years old), mostly had paroxysmal character (84.5%), in 82.1% of cases was accompanied by marked clinical symptoms: sense of disruption of the heart (50%), feeling short of breath (28.6%), <z:mp ids='MP_0000746'>weakness</z:mp> (17.9%) </plain></SENT>
<SENT sid="3" pm="."><plain>In 87% of casesclinical symptomatology required calls for medical emergencies </plain></SENT>
<SENT sid="4" pm="."><plain>In 42.9% of cases uncontrolled <z:hpo ids='HP_0000822'>hypertension</z:hpo> was possible predisposing factor for developing AF </plain></SENT>
<SENT sid="5" pm="."><plain>Paroxysmal AF moved to constant in 38.8% of patients during the period from 1 year to 18 years </plain></SENT>
<SENT sid="6" pm="."><plain>Due to the high risk of thromboembolic complications (2 to 5 on a scale of CHADS2), after the detection AF <z:chebi fb="8" ids="10033">warfarin</z:chebi> was shown to 96.6% of patients, because of the high risk of <z:mp ids='MP_0001914'>bleeding</z:mp> in practice was appointed only 37.9% </plain></SENT>
<SENT sid="7" pm="."><plain>Complications of therapy in the form of <z:mp ids='MP_0001914'>bleeding</z:mp> were 9.1% </plain></SENT>
<SENT sid="8" pm="."><plain>Tactics of rhythm control by antiarrhythmic drugs I and III classes has remained in 36.7% of patients with paroxysmal AF </plain></SENT>
<SENT sid="9" pm="."><plain>-adrenoblockers were constantly taken by 63.3% of the patients using antiarrhythmic drugs I and III classes for relief of <z:hpo ids='HP_0011675'>arrhythmia</z:hpo> during her recurrence (the strategy of "pill in pocket") </plain></SENT>
</text></document>